High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
View ORCID ProfileChristiana Franke, Caroline Ferse, View ORCID ProfileJakob Kreye, View ORCID ProfileS Momsen Reincke, View ORCID ProfileElisa Sanchez-Sendin, View ORCID ProfileAndrea Rocco, View ORCID ProfileMirja Steinbrenner, View ORCID ProfileStefan Angermair, View ORCID ProfileSascha Treskatsch, Daniel Zickler, View ORCID ProfileKai-Uwe Eckardt, View ORCID ProfileRick Dersch, View ORCID ProfileJonas Hosp, View ORCID ProfileHeinrich J. Audebert, View ORCID ProfileMatthias Endres, View ORCID ProfileChristoph J. Ploner, View ORCID ProfileHarald Prüss
doi: https://doi.org/10.1101/2020.07.01.20143214
Christiana Franke
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
MDCaroline Ferse
3Department of Nephrology and Medical Intensive Care, Charité—Universitätsmedizin Berlin
MDJakob Kreye
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
2German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany
6Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany
MDS Momsen Reincke
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
2German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany
11Berlin Institute of Health (BIH), 10178 Berlin, Germany
MDElisa Sanchez-Sendin
2German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany
PhD, MDAndrea Rocco
4Department of Neurology, Ernst-von-Bergmann Klinikum, Potsdam, Germany
MDMirja Steinbrenner
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
MDStefan Angermair
5Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
MDSascha Treskatsch
5Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
MDDaniel Zickler
3Department of Nephrology and Medical Intensive Care, Charité—Universitätsmedizin Berlin
MDKai-Uwe Eckardt
3Department of Nephrology and Medical Intensive Care, Charité—Universitätsmedizin Berlin
MDRick Dersch
7Clinic of Neurology and Neurophysiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
MDJonas Hosp
7Clinic of Neurology and Neurophysiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
MDHeinrich J. Audebert
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
MDMatthias Endres
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
2German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany
8Center for Stroke Research Berlin, Berlin, Germany
9Excellence Cluster NeuroCure, Berlin, Germany
10German Centre for Cardiovascular Research (DZHK), Berlin, Germany
MDChristoph J. Ploner
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
MDHarald Prüss
1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
2German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany
MDData Availability
All data is available by request.
Posted July 06, 2020.
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
Christiana Franke, Caroline Ferse, Jakob Kreye, S Momsen Reincke, Elisa Sanchez-Sendin, Andrea Rocco, Mirja Steinbrenner, Stefan Angermair, Sascha Treskatsch, Daniel Zickler, Kai-Uwe Eckardt, Rick Dersch, Jonas Hosp, Heinrich J. Audebert, Matthias Endres, Christoph J. Ploner, Harald Prüss
medRxiv 2020.07.01.20143214; doi: https://doi.org/10.1101/2020.07.01.20143214
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
Christiana Franke, Caroline Ferse, Jakob Kreye, S Momsen Reincke, Elisa Sanchez-Sendin, Andrea Rocco, Mirja Steinbrenner, Stefan Angermair, Sascha Treskatsch, Daniel Zickler, Kai-Uwe Eckardt, Rick Dersch, Jonas Hosp, Heinrich J. Audebert, Matthias Endres, Christoph J. Ploner, Harald Prüss
medRxiv 2020.07.01.20143214; doi: https://doi.org/10.1101/2020.07.01.20143214
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (463)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)